Posted 4 апреля 2022,, 11:35
Published 4 апреля 2022,, 11:35
Modified 24 декабря 2022,, 22:36
Updated 24 декабря 2022,, 22:36
Rospotrebnadzor (Russian Federal State Agency for Health and Consumer Rights) pointed out that obtaining data on the concentration of antibodies in citizens is important for understanding the degree of protection against re-disease. The effectiveness of the new system has been confirmed by clinical and laboratory tests. The reagent kit is currently approved for circulation in the country.